pharmaphorum

JANUARY 26, 2022

Immunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval for a cancer therapeutic based on T cell receptor (TCR) technology. The US regulator cleared the company’s lead TCR Kimmtrak (tebentafusp; formerly IMCgp100 ) – a bispecific T cell engager (BiTE) that consists of a soluble TCR targeting gp100 expressed on cancer cells fused to a protein that binds CD3 receptors on lymphocytes – as a treatment for unresectable or metastatic uveal me

FDA 115

FDA Chemotherapy Labelling Immunization 115

Fierce Healthcare

JANUARY 26, 2022

Senate health leaders preview bipartisan plan to overhaul the nation's public health response. dmuoio. Wed, 01/26/2022 - 12:17.

119

119

pharmaphorum

JANUARY 26, 2022

The final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020. The data from CB Insights’ annual State of Digital Health report notes that the record investments were apparent across all geographies and were “fuelled by the growing need to provide digital solutions and delivery models to patients during the pandemic.” Highlights of the year included an a

100

100

Fierce Healthcare

JANUARY 26, 2022

Number of ACOs increases modestly to 483 for 2022, which advocates say should be wake-up call. rking. Wed, 01/26/2022 - 13:36.

119

119

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 26, 2022

We have seen a boom in biotech initial public offerings over the last two years, but many of Europe’s offerings have migrated to the United States. So, what can we do to keep home-grown science on European soil? From the Pfizer/BioNTech and Oxford/AstraZeneca vaccines to GSK’s lifesaving antibody treatments, European innovation has played a crucial role in the global response to COVID-19.

Communication 101

Communication Vaccines 101

Fierce Healthcare

JANUARY 26, 2022

Uber taps first chief medical officer for growing healthcare arm. rtorrence. Wed, 01/26/2022 - 16:24.

124

124

Fierce Healthcare

JANUARY 26, 2022

Health cost regulator tells Mass General Brigham to clamp down on spending, critiques $2B expansion plan. dmuoio. Wed, 01/26/2022 - 15:23.

98

98

Outsourcing Pharma

JANUARY 26, 2022

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

59

59

Fierce Healthcare

JANUARY 26, 2022

Biden admin redirected nearly $7B of provider relief to COVID vaccine, therapeutics purchases: report. dmuoio. Wed, 01/26/2022 - 16:22.

Vaccines 98

Vaccines 98

NICE

JANUARY 26, 2022

NICE has recently published a guideline on Shared decision making (nice.org.uk) (SDM) which defines SDM as a collaborative process involving a person and their healthcare professional working together to reach a joint decision about care. In essence, the clinician provides evidence-based information using a variety of tools and techniques to describe risks and benefits and encourages the person to express their beliefs, values, and choices.

Packaging 52

Packaging 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 26, 2022

NextGen Healthcare eyes opportunities to build up RCM business amid tight healthcare labor market. hlandi. Wed, 01/26/2022 - 12:04.

98

98

pharmaphorum

JANUARY 26, 2022

Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change. With drawn-out timelines and billions in investments, traditional clinical trial methods are increasingly a barrier to cost-efficient and timely drug development. Synthetic data is addressing this head-on by harnessing historical clinical trials and real-world data to create simulation scenarios and optimise protocol design.

52

52

Fierce Healthcare

JANUARY 26, 2022

Maven Clinic adds new positions to focus on evidence-based care redesign. agliadkovskaya. Wed, 01/26/2022 - 09:59.

105

105

pharmaphorum

JANUARY 26, 2022

Johnson & Johnson has said the impending spin-off of its consumer health division won’t stop it from “forging ahead” with M&A deals to expand its other businesses including pharma and medical devices. Joaquin Duato. On a conference call to discuss the company’s fourth-quarter results, new chief executive Joaquin Duato said the focus will continue to be on “tuck-in” deals to help fill its R&D pipeline, but said he would also consider larger deals &#

Vaccines 52

Vaccines 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 26, 2022

Anthem reports $1.1B in profit for Q4, doubling its haul year over year. pminemyer. Wed, 01/26/2022 - 07:52.

98

98

Outsourcing Pharma

JANUARY 26, 2022

One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.

52

52

Fierce Healthcare

JANUARY 26, 2022

Golden parachute payouts worth $20M for Cerner's Feinberg, former CEO with proposed sale to Oracle. hlandi. Wed, 01/26/2022 - 13:37.

Cerner 81

Cerner 81

Outsourcing Pharma

JANUARY 26, 2022

A leader from the RBQM solutions specialists offers a preview of his SCOPE 2022 presentation on tools suited to decentralized trial design and management.

52

52

Med Ed 101

JANUARY 26, 2022

JE is a 71-year-old female with a history of Polymyalgia Rheumatica (PMR), osteoporosis, GERD, hypertension, and hyperlipidemia. Her current medications include: Alendronate 70 mg weekly Prednisone 15 mg daily Vitamin D 2,000 units daily Omeprazole 20 mg daily Losartan 50 mg daily Atorvastatin 20 mg daily Polymyalgia Rheumatica (PMR) is a diagnosis you are likely […].

40

40

Pharma Marketing Network

JANUARY 26, 2022

Westlake Village BioPartners’ Beth Seidenberg, Bristol Myers Squibb’s Christopher Boerner, and CEEK Women’s Health’s Wendy White Earn Top Industry Honors. FAIRFIELD, NJ (25 January, 2022) – The Healthcare Businesswomen’s Association (HBA) announces the 2022 Woman of the Year, Honorable Mentor, and STAR. The honorees recognized for their significant contributions to healthcare and the advancement of women in the industry will be recognized at the HBA’s 32nd annual Woman of the Year event on 10 M

40

40

pharmaphorum

JANUARY 26, 2022

The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences’ magrolimab, the centre piece of its $4.9 billion acquisition of Forty Seven in 2020. The regulatory move applies only to trials of magrolimab given alongside Bristol-Myers Squibb’s Vidaza (azacitidine), and stems from an “imbalance” in investigator-reported serious adverse events between study arms, said the drugmaker.

FDA 40

FDA Adverse Reactions Chemotherapy Immunization 40

Druggist

JANUARY 26, 2022

. . The post COVID-19 lateral flow tests available from pharmacies appeared first on Druggist.Online.

40

40

Pharma Times

JANUARY 26, 2022

COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for specific Omicron jab

Vaccines 41

Vaccines 41

Pharma Times

JANUARY 26, 2022

Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments

41

41